| 摘要 |
This invention relates to pharmaceutical compositions mainly comprising a polypeptide, for example calcitonin, and co-freeze-dried lysogangliosides for oral administration in the form of gastric-protected capsules and/or tablets so as to promote absorption and bioavailability of the calcitonin without creating biological imbalances in the organs and tissues which come into contact with the compounds used in the formulations. |
